Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

NCT07674290 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Bardet Biedl Syndrome (BBS)
Bardet Biedl Syndrome
Bardet-Biedl Syndrome (BBS)
Alstrom Syndrome

Interventions

DRUG: Setmelanotide

Sponsor

Tom Hühne

Collaborators

[object Object]